Icahn Offers Nearly $5 Bln for Mylan Labs
550625
Financier Carl Icahn on Friday  offered to buy the shares of generic drugmaker Mylan  Laboratories MYL.N that he does not already own for $4.9  billion, or $20 a share, according to a government filing.
723686
FOSTER CITY, Calif. -- Gilead Sciences Inc., a drug research company, said Monday it plans to buy Myogen Inc. for about $2.5 billion in cash, giving Gilead access to Myogen's heart-drug candidates.
189520
Shares of Mylan Laboratories Inc., the largest US maker of generic drugs, surged Thursday after the company said investor Carl Icahn was given the green light by regulators to buy up to $500 million of the company&#39;s stock.
351525
U.S. investors Carl Icahn and Warren  Lichtenstein are preparing a tender offer for KT&amp;G Corp. , a  South Korean brokerage said, sending shares of the country&#039;s  top tobacco maker up over 6 percent on Friday.
272040
Billionaire investor Carl Icahn and a group of investors are opposing yet another corporate takeover. The investors, led by Icahn, have accumulated a 7 percent stake in Mylan Laboratories Inc.
580086
WASHINGTON (CBS.MW) -- Mylan Laboratories (MYL) , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals (KG) is in the long-term interest of the generic drugmaker and its
639218
NEW YORK, November 22  - Mylan Labsâ (MYL.NYS) board of directors rejected investor Carl Icahnâs takeover bid today, terming his offer letter as a self serving publicity stunt, while reiterating the companyâs intention to proceed
754264
PHILADELPHIA, Aug 19  - Shares of Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) surged more than 10 percent on Thursday after billionaire investor Carl Icahn got federal regulatory approval to buy up 11.9 percent of ...
255702
A real estate company majority-owned by billionaire Carl Icahn offered on Monday to acquire Reckson Associates Realty Corp.  and an affiliate company for $49 per share, or a total of $4.3 billion in cash and stock.
626345
Mylan Laboratories Inc.&#39;s (MYL.N: Quote, Profile, Research) board on Monday rebuffed financier Carl Icahn&#39;s bid to buy the company, and said it remains committed to
71455
'This will hurt you more than it hurts me' Oracle let its $17 per share offer for BEA lapse yesterday, but activist investor Carl Icahn has demanded the middleware firm put the offer to shareholders anyway.â¦
664157
Financier Carl Icahn on Friday offered to buy the shares of generic drugmaker Mylan Laboratories that he does not already own for $4.9 billion, or $20 a share, according to a government filing.
750826
Auto parts supplier Lear Corp.  said on Monday that a company affiliated with activist investor Carl Icahn has offered to buy the company for $36 per share in cash.
326818
Financier Carl Icahn on Monday said King Pharmaceutical Inc.&#39;s (KG) possible need to restate earnings reinforces his belief that an acquisition of King by Mylan Laboratories Inc.
97449
Investor Carl Icahn on Thursday detailed his objections to Mylan Laboratories Inc.&#39;s proposed $4 billion acquisition of King Pharmaceuticals Inc.
755767
Mylan Laboratories Inc.'s MYL.N board  on Monday rebuffed financier Carl Icahn's bid to buy the  company, and said it remains committed to its $3.37 billion  purchase of brand-name drug-maker King Pharmaceuticals Inc.  KG.N.
479586
Station Casinos Inc.  has accepted a revised buyout offer valued at about $5.5 billion from a group that includes the company's founding family and real-estate firm Colony Capital LLC, according to The Wall Street Journal.